Roche Holding AG (RHHBY)

OTC Markets OTCQX • Currently down 0.25 (-0.45%) in today's trading session

10 members of Congress have disclosed 68 trades in Roche Holding AG (RHHBY) via STOCK Act filings. The most recent disclosure was a sale by Ritchie Torres on 11 July 2025. The most active traders have been Lois Frankel (16), Mikie Sherrill (10), and Shelley Moore Capito (10). Aggregate disclosed activity totals roughly $240K in purchases and $272K in sales (midpoint estimates from bracketed disclosure amounts).

Roche Holding AG is currently trading at $54.97, positioned at 72% of its 52-week range ($39.50 – $60.85).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$54.97
24h Change
-0.25 (-0.45%)
52 Week Range
$39.50–$60.85
View on NASDAQ

Roche Holding AG Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for RHHBY

Select to highlight on chart
5 transactions
Compliance: 51%
Ritchie Torres11 Jul 202520 Aug 2025SaleStock$1,001 - $15,000N/A
Bruce Westerman21 Apr 202512 May 2025SaleStock$1,001 - $15,000N/A
Bruce Westerman21 Apr 202511 Aug 2026SaleStock$1,001 - $15,000N/A
Bruce Westerman3 Mar 202516 Apr 2025PurchaseStock$1,001 - $15,000N/A
Bruce Westerman3 Mar 202511 Aug 2026PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$350.35B

Volume

140.75K

Beta

0.35

P/E Ratio

17.73

Fundamentals

EPS

$3.10

Div. Yield

2.82%

Open

$54.58

Day Range

$54.52 – $55.18

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
CH
CEO
Thomas Schinecker
IPO Date
2003-08-20
Website
www.roche.com

Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international presence, with key operations located in countries...

Earnings

Next Report

Q4 2026

4 Feb

EPS Est.

$1.49

Rev. Est.

$39.8B

Days Until

150

Recent Quarters

Q2 202623 Jul
EPS$1.66
Beat 5.1%
Q4 202529 Jan
EPS$1.36
Beat 0.7%
Q2 202524 Jul
EPS$1.74
Beat 7.4%
Q4 202430 Jan
EPS$1.18
Beat 0.8%
Q2 202422 Jul
EPS$1.43
Beat 10.0%
Q4 20231 Feb
EPS$1.23
Beat 0.8%
Q2 202327 Jul
EPS$1.45
Miss 2.7%
Q4 20222 Feb
EPS$1.14
Miss 4.2%
Q2 202221 Jul
EPS$1.52
Beat 7.8%
Q4 20213 Feb
EPS$1.26
Miss 4.5%
Q2 202122 Jul
EPS$1.44
Beat 4.3%
Q4 20201 Feb
EPS$1.21
Miss 2.4%
Q2 202023 Jul
EPS$1.41
Beat 0.0%
Q4 201930 Jan
EPS$1.17
Beat 0.9%

17 politicians traded within 30 days

Dividends

Dividend History

13 Mar 2026
Amount $1.5495
28 Mar 2025
Amount $1.3890
14 Mar 2024
Amount $1.3494
16 Mar 2023
Amount $1.2794
17 Mar 2022
Amount $1.2407
18 Mar 2021
Amount $1.2206
19 Mar 2020
Amount $1.1366
7 Mar 2019
Amount $1.0746
15 Mar 2018
Amount $0.8918
15 Mar 2017
Amount $0.8458
2 Mar 2016
Amount $1.0178
4 Mar 2015
Amount $1.0039
6 Mar 2014
Amount $1.1090
7 Mar 2013
Amount $0.9694
8 Mar 2012
Amount $0.9212
3 Mar 2011
Amount $0.8843
4 Mar 2010
Amount $0.6959
11 Mar 2009
Amount $0.5271
4 Mar 2008
Amount $0.5630
5 Mar 2007
Amount $0.3452
27 Feb 2006
Amount $0.2385
28 Feb 2005
Amount $0.2093
6 Apr 2004
Amount $0.1580
1 Apr 2003
Amount $0.1310
16 Apr 2002
Amount $0.0986
3 Apr 2001
Amount $0.0842
5 Jun 2000
Amount $0.3860
9 May 2000
Amount $0.0726
23 Apr 1999
Amount $0.0718
5 May 1998
Amount $0.0700
6 May 1997
Amount $0.0938
31 May 1996
Amount $0.0450
26 May 1995
Amount $0.0688
27 May 1994
Amount $0.0600
25 May 1993
Amount $0.0463

Stock Splits

Split History

27 Feb 2014Stock Split
Ratio2:1
9 Jan 2009Stock Split
Ratio2:1
25 Jan 2005Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

JNJ

Johnson & Johnson

74
$275.23-3.20 (-1.15%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

REGN

Regeneron Pharmaceuticals, Inc.

74
$827.72-15.75 (-1.87%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

GILD

Gilead Sciences, Inc.

74
$151.00-0.22 (-0.15%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

Frequently Asked Questions about RHHBY

Which members of Congress have traded RHHBY?
10 members of Congress have disclosed 68 trades in Roche Holding AG (RHHBY) under the STOCK Act. The most active traders are Lois Frankel, Mikie Sherrill, and Shelley Moore Capito.
When was RHHBY most recently disclosed by Congress?
The most recent RHHBY disclosure was a sale by Ritchie Torres on 11 July 2025.
What is the total disclosed congressional trading volume for RHHBY?
Members of Congress have disclosed approximately $240K in RHHBY purchases and $272K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in RHHBY?
This RHHBY page updates as soon as new STOCK Act disclosures are filed for Roche Holding AG. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.